Delivery Order SPE2DR25D3301-SPE2DR26F18DG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 MG tablets (30-count supply) valued at $1,752.54 under a firm fixed price contract type. The delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/mL oral suspension (340 mL) on July 14, 2025, with a ceiling value of $1,935.66. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. FYCOMPA is an antiepileptic medication...
- The Defense Logistics Agency awarded a $6,828.86 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340ml) on November 7, 2025, with completion targeted for November 10, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,903.46 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of FYCOMPA 0.5 mg/ml oral suspension (340ml). This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.95 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340 ml unit. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,965.36 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on May 30, 2025, with a completion date of June 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for FYCOMPA 4 mg tablets (30-count package) with a ceiling value of $2,067.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 24, 2025, and the place of performance is located in Conshohocken, PA. This delivery...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $1,224.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is an oral antiepileptic medication used in the treatment of seizure disorders, reflecting the Defense Logistics Agency...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18DGDelivery Order
The Defense Logistics Agency awarded a $3,051.22 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/mL oral suspension (340 mL) on November 17, 2025, with completion scheduled for November 18, 2025. This is a firm fixed-price, non-set-aside contract representing a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. FYCOMPA is a perampanel-based neurological medication used to treat epilepsy, reflecting AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare programs. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements through open competition, with delivery orders typically featuring firm fixed pricing across varying transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/17/25 |